Precision Optics (NASDAQ:POCI) Announces Earnings Results

Precision Optics (NASDAQ:POCI) issued its earnings results on Tuesday. The company reported ($0.23) EPS for the quarter, FiscalAI reports. Precision Optics had a negative net margin of 28.31% and a negative return on equity of 53.29%. The firm had revenue of $7.37 million during the quarter.

Precision Optics Stock Performance

POCI traded down $0.10 on Tuesday, hitting $4.66. The company had a trading volume of 21,935 shares, compared to its average volume of 25,545. The stock has a market cap of $35.98 million, a price-to-earnings ratio of -5.55 and a beta of 0.32. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.29 and a quick ratio of 0.79. The company’s fifty day moving average price is $4.58 and its 200 day moving average price is $4.51. Precision Optics has a 1-year low of $3.77 and a 1-year high of $6.04.

Institutional Trading of Precision Optics

A number of institutional investors and hedge funds have recently modified their holdings of the company. DRW Securities LLC acquired a new position in Precision Optics in the 4th quarter valued at $94,000. Needham Investment Management LLC boosted its holdings in Precision Optics by 2.9% during the fourth quarter. Needham Investment Management LLC now owns 720,000 shares of the company’s stock valued at $3,013,000 after acquiring an additional 20,000 shares during the period. Jane Street Group LLC acquired a new stake in shares of Precision Optics in the fourth quarter valued at about $48,000. Citadel Advisors LLC acquired a new position in shares of Precision Optics during the 3rd quarter worth about $49,000. Finally, WealthTrust Axiom LLC lifted its position in shares of Precision Optics by 2.7% during the 4th quarter. WealthTrust Axiom LLC now owns 231,808 shares of the company’s stock worth $970,000 after purchasing an additional 6,158 shares during the last quarter. 13.71% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.